Butterfly Network stock
BFLYNYSEButterfly Network, Inc., HealthcareISIN US1241551027
45Score 45 out of 100, Weak
Price and trend
71 / 100
Price history
+195% in one yearThe chart shows daily closes over 6 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 8.6% above it.
Since November 2025 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 49).
The price is 33% below its 52-week high. Largest decline in 6 years: 97% (February 2021 to April 2024).
Chart figures for advanced users
- SMA 50$7.70
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$6.14
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)49
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$1.97
- The lowest closing price of the last twelve months.
- Resistance$9.93
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Butterfly Network, Inc. belongs to the Medical (Devices) industry (United States) and, with a market value of $1.78B, is number 41 of 88 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $97.61M (up 19% year on year) and a loss of $77.06M.
- For fiscal 2026, analysts expect on average revenue of $124.86M (up 27.9%) and adjusted earnings per share of −$0.06.
Show more
- MEQIRI Score 45 out of 100 (Weak): rank 448 of 702 in Healthcare, median 53.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- More cash than debtCash $122.3M, financial debt $18.41M.Stability 53
Weaknesses
- DilutionShare count up 42% since 2021.Capital allocation 18
- Volatile share priceVolatility 121% a year over the last 12 months.Stability 53
- Loss-makingLoss of $53.69M over the last 12 months.Fundamentals 17
Its standout strengths are momentum and technical analysis, while capital allocation and fundamentals hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 46 to 45.
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansValuation
Valuation signal
not measuredA fair value is not meaningful here, so the signal follows the valuation grade.
Valuation metrics
The model puts the fair value at less than a quarter of the share price. That says more about the assumptions than about the company, so a fair value is not meaningful here and the valuation relies on the P/E and the other metrics.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 39.4% on the twelve months before. Revenue has grown strongly since 2018, at around 81% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 47%, operating −89%, net −79%. Last 12 months: net −44%.
Debt & balance sheet
latest quarterDebt is low, but interest coverage is weak. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 25 Feb 2027in 104 days
- Last reported
- 29 Oct 2026EPS reported −$0.01 (expected −$0.04)above expectations
Analyst estimates
Analysts have raised their 2026 earnings estimate by 40.9% since 15 Oct 2026.
- Earnings per share
- −$0.06+40.9%
- Revenue
- $124.86M+2.7%
- Earnings per share
- −$0.06+13.7%
- Revenue
- $149.34M0.0%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: −18.2%Butterfly Network raised its full year 2026 guidance: revenue now expected at $123 million to $126 million (up $4 million at the low end and $3 million at the high end from prior guidance), and adjusted EBITDA loss now expected at $12 million to $15 million, an improvement of $7 million to $8 …
“We expect our Adjusted EBITDA loss to be between $12 million and $15 million, an improvement of $8 million at the bottom and $7 million at the top of the range from our previous guidance. This implies an Adjusted EBITDA loss between $3 million and $6 million for the Q4.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 29 Oct 2026 (fiscal Q3 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
One insider bought on the open market in the last 6 months, $999,510 in total. 8 insiders sold, $95.2M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Devivo JosephSale
30 Oct 2026, President & CEO
- Shares
- 90,600
- Price
- $7.01
- Value
- $634,925
- Devivo JosephSale
6 Oct 2026, President & CEO
- Shares
- 35,790
- Price
- $10.02
- Value
- $358,616
- Carlson MeganSale
2 Oct 2026, CAO and SVP, Finance
- Shares
- 10,114
- Price
- $8.75
- Value
- $88,447
Show 31 more
- Devivo JosephSale
23 Sept 2026, President & CEO
- Shares
- 3,169
- Price
- $10.02
- Value
- $31,757
- Devivo JosephSale
22 Sept 2026, President & CEO
- Shares
- 2,811
- Price
- $10.00
- Value
- $28,110
- Cashman SteveSale
4 Sept 2026, Chief Business Officer
- Shares
- 140,112
- Price
- $7.30
- Value
- $1.02M
- Carlson MeganSale
4 Sept 2026, CAO and SVP, Finance
- Shares
- 13,804
- Price
- $7.30
- Value
- $100,797
- Caezza NicholasSale
2 Sept 2026, Deputy General Counsel
- Shares
- 1,709
- Price
- $8.15
- Value
- $13,927
- Robbins LarrySale
17 Aug 2026, Board
- Shares
- 582,500
- Price
- $8.97
- Value
- $5.23M
- Robbins LarrySale
14 Aug 2026, Board
- Shares
- 824,700
- Price
- $8.70
- Value
- $7.17M
- Phanstiel S. LouisePurchase
14 Aug 2026, Board
- Shares
- 115,200
- Price
- $8.68
- Value
- $999,510
- Robbins LarrySale
13 Aug 2026, Board
- Shares
- 890,533
- Price
- $9.24
- Value
- $8.22M
- Caezza NicholasSale
11 Aug 2026, Deputy General Counsel
- Shares
- 10,000
- Price
- $9.75
- Value
- $97,500
- Devivo JosephSale
10 Aug 2026, President & CEO
- Shares
- 68,346
- Price
- $10.01
- Value
- $684,075
- Robbins LarrySale
3 Aug 2026, Board
- Shares
- 156,163
- Price
- $8.10
- Value
- $1.27M
- Carlson MeganSale
31 Jul 2026, CAO and SVP, Finance
- Shares
- 68,852
- Price
- $7.86
- Value
- $541,383
- Robbins LarrySale
31 Jul 2026, Board
- Shares
- 1,720,129
- Price
- $7.39
- Value
- $12.72M
- Rothberg Jonathan MSale
22 Jul 2026, Board
- Shares
- 36,366
- Price
- $6.47
- Value
- $235,281
- Rothberg Jonathan MSale
21 Jul 2026, Board
- Shares
- 753,320
- Price
- $6.74
- Value
- $5.07M
- Rothberg Jonathan MSale
20 Jul 2026, Board
- Shares
- 1,177,276
- Price
- $6.61
- Value
- $7.79M
- Ku VictorSale
20 Jul 2026, Chief Technology Officer
- Shares
- 48,540
- Price
- $6.56
- Value
- $318,422
- Doherty John N.Sale
20 Jul 2026, EVP, CFO
- Shares
- 57,136
- Price
- $6.56
- Value
- $374,812
- Devivo JosephSale
20 Jul 2026, President & CEO
- Shares
- 211,798
- Price
- $6.56
- Value
- $1.39M
- Rothberg Jonathan MSale
17 Jul 2026, Board
- Shares
- 1,195,857
- Price
- $6.60
- Value
- $7.89M
- Rothberg Jonathan MSale
16 Jul 2026, Board
- Shares
- 1,467,501
- Price
- $7.09
- Value
- $10.4M
- Rothberg Jonathan MSale
15 Jul 2026, Board
- Shares
- 1,730,319
- Price
- $7.32
- Value
- $12.67M
- Rothberg Jonathan MSale
14 Jul 2026, Board
- Shares
- 815,632
- Price
- $7.72
- Value
- $6.29M
- Ku VictorSale
7 Jul 2026, Chief Technology Officer
- Shares
- 35,649
- Price
- $7.87
- Value
- $280,665
- Doherty John N.Sale
7 Jul 2026, EVP, CFO
- Shares
- 55,229
- Price
- $7.87
- Value
- $434,818
- Devivo JosephSale
7 Jul 2026, President & CEO
- Shares
- 204,725
- Price
- $7.87
- Value
- $1.61M
- Carlson MeganSale
2 Jul 2026, CAO and SVP, Finance
- Shares
- 41,303
- Price
- $7.96
- Value
- $328,937
- Cashman SteveSale
8 Jun 2026, Chief Business Officer
- Shares
- 294,680
- Price
- $4.66
- Value
- $1.37M
- Cashman SteveSale
5 Jun 2026, Chief Business Officer
- Shares
- 104,781
- Price
- $4.96
- Value
- $520,133
- Caezza NicholasSale
2 Jun 2026, Deputy General Counsel
- Shares
- 1,733
- Price
- $4.52
- Value
- $7,831
Partial trades from one filing are shown in one row, with the average price.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Butterfly Network
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
702 rated companies in Healthcare
- This company
- 45
- Sector median
- 53
Categories against the sector medianMedian of 702 companies
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Medical (Devices)
The next larger and next smaller companies by market value
- UFP TechnologiesUFPT $2.37B76
- Drägerwerk AG & Co. KGaADRW3.DE $2.31B66
- ElektaEKTA-B.ST $2.27B56
- Establishment Labs HoldingsESTA $2.05B41
- Embla Medical hf.EMBLA.CO $1.76B67
- ChemoMetecCHEMM.CO $1.76B78
- Inspire Medical SystemsINSP $1.75B52
- Medartis HoldingMED.SW $1.63B55
ETFs that hold Butterfly Network
Held by 10 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ | 0.06% | 0.30% | €185.82M |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.05% | 0.30% | €2.22B |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.05% | 0.30% | €4.28B |
Show 5 more
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.02% | 0.43% | €2.5B |
| State Street SPDR MSCI World Small Cap UCITS ETF (Acc)ZPRS | 0.01% | 0.45% | €1.53B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.01% | 0.10% | €395.74M |
| UBS MSCI USA Select Factor Mix UCITS ETF USD accUSUE | 0.00% | 0.25% | €175.89M |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.00% | 0.30% | €944.34M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 28 Feb 2025)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.